Cite
HARVARD Citation
Agnarelli, A. et al. (2022). Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4‐MYC oncogenic axis in multiple myeloma. Hematological oncology. 40 (3), pp. 417-429. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Agnarelli, A. et al. (2022). Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4‐MYC oncogenic axis in multiple myeloma. Hematological oncology. 40 (3), pp. 417-429. [Online].